President Trump’s Condition: Regeneron CEO and Dr. Scott Gottlieb on POTUS Treatment
Squawk Pod5 Okt 2020

President Trump’s Condition: Regeneron CEO and Dr. Scott Gottlieb on POTUS Treatment

President Trump remains at Walter Reed National Military Medical Center, and treatments for his coronavirus diagnosis include an experimental antibody cocktail from Regeneron, dexamethasone, and Gilead’s remdesivir. CNBC’s Eamon Javers tracks the timeline of events since the President’s announcement, and CNBC’s Meg Tirrell explains the drugs in the President’s treatment plans. Former FDA Commissioner Dr. Scott Gottlieb deciphers the President’s likely condition from White House communications, and Regeneron CEO Dr. Leonard Schleifer discusses the status of the monoclonal antibody cocktail that was approved by the FDA for “compassionate use” in President Trump’s treatment.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Avsnitt(1871)

Labor Market Metrics in a Shutdown 10/1/25

Labor Market Metrics in a Shutdown 10/1/25

Hours into the first government shutdown in over six years, Punchbowl News co-founder Jake Sherman reports on the path forward for both sides of the aisle. The Bureau of Labor Statistics will not rele...

1 Okt 202536min

5 Things to Know Before the Opening Bell 10/1/2025

5 Things to Know Before the Opening Bell 10/1/2025

Friday’s employment report is unlikely to be released due to the government shutdown, the White House is pulling the nomination of economist E.J. Antoni to lead the Bureau of Labor Statistics, Tesla i...

1 Okt 20253min

The Shutdown Episode: Speaker Johnson & Minority Leader Jeffries 9/30/25

The Shutdown Episode: Speaker Johnson & Minority Leader Jeffries 9/30/25

As a government shutdown looms in Washington, House Speaker Mike Johnson (R-Louisiana) discusses friction between the Republicans and Democrats that’s delaying progress on the Hill. House Minority Lea...

30 Sep 202548min

Jim Cramer, “How to Make Money in Any Market,” & NYC Politics 9/29/25

Jim Cramer, “How to Make Money in Any Market,” & NYC Politics 9/29/25

CNBC’s Jim Cramer is out with a new book this week, “How to Make Money in Any Market.” He joins Becky Quick and Andrew Ross Sorkin on the Squawk Box set to discuss his perspective on the markets, the ...

29 Sep 202541min

5 Things to Know Before the Opening Bell 9/29/2025

5 Things to Know Before the Opening Bell 9/29/2025

The 5 things you need to know before the stock market opens today: Jeep-maker Stellantis has a new CFO, the CEO of British drugmaker GSK is stepping down, SEC Chair Paul Atkins is moving to fast track...

29 Sep 20251min

Global Takes on a TikTok Deal & “The Creative Shift” 9/26/25

Global Takes on a TikTok Deal & “The Creative Shift” 9/26/25

President Trump has approved a TikTok deal; CNBC’s Eamon Javers, in Washington, and Eunice Yoon, in Beijing, discuss the geopolitics playing out through the social media platform’s business. A governm...

26 Sep 202545min

5 Things to Know Before the Opening Bell 9/26/2025

5 Things to Know Before the Opening Bell 9/26/2025

The 5 things you need to know before the stock market opens today: President Trump has announced new tariffs on pharmaceuticals and trucks, and he’s suggested sharing that revenue with American farmer...

26 Sep 20252min

Shutdown, What Shutdown? & Kodiak’s Nasdaq Launch

Shutdown, What Shutdown? & Kodiak’s Nasdaq Launch

The White House warned federal agencies to prepare for mass firings if Congress does not reach a deal to fund the government by midnight on October 1st. CNBC’s Emily Wilkins describes the warning, and...

25 Sep 202535min

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-jossan-nina
rss-borsens-finest
avanzapodden
uppgang-och-fall
bathina-en-podcast
svd-tech-brief
borsmorgon
fill-or-kill
rss-kort-lang-analyspodden-fran-di
lastbilspodden
affarsvarlden
loungepodden
rikatillsammans-om-privatekonomi-rikedom-i-livet
kapitalet-en-podd-om-ekonomi
dynastin
rss-inga-dumma-fragor-om-pengar
rss-dagen-med-di